ÂÜÀòÂÒÂ×

Jeffrey B. Kindler has more than three decades of business experience and has held leadership positions at some of the world’s most recognized companies. He is currently the Chief Executive Officer of Centrexion Therapeutics Corporation. Mr. Kindler also serves as an Operating Partner of Artis Ventures and serves as a board member of a number of public and private health and consumer care companies. Prior to joining Centrexion, Mr. Kindler was the Chairman and CEO of Pfizer Inc., a leading pharmaceutical company. As CEO, he led Pfizer’s $68 billion mergers and acquisition of Wyeth, diversified its product portfolio, improved its research and development pipeline, and reshaped the company’s commercial, innovation, and leadership models to drive growth and cultural change. Earlier in his career, he served as the Executive Vice President and General Counsel for McDonald’s Corporation and was the Vice President of Litigation and Legal Policy for the General Electric Company (GE). Prior to GE, he practiced civil and criminal litigation as a Partner of Williams & Connolly. Mr. Kindler holds a B.A. from Tufts University and a J.D. from Harvard University.